BTIG Initiates Coverage On IperionX with Buy Rating, Announces Price Target of $40

Benzinga Newsdesk www.benzinga.com Neutral 60.9%

Neg 0% Neu 60.9% Pos 0%

BTIG analyst Gregory Lewis initiates coverage on IperionX (NASDAQ:IPX) with a Buy rating and announces Price Target of $40.